US2018214565A1PendingUtilityA1

Peptide having cell membrane penetrating activity

57
Assignee: UNIV EWHA IND COLLABORATIONPriority: Feb 20, 2006Filed: Jan 22, 2018Published: Aug 2, 2018
Est. expiryFeb 20, 2026(expired)· nominal 20-yr term from priority
Inventors:Kyunglim Lee
A61P 43/00A61K 47/65C07K 14/46C07K 14/435C07K 7/08A61K 47/64A61K 48/0008C07K 14/47C07K 16/18C07K 7/06C07K 7/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are transmembrane complexes that contain a protein transduction domain (PTD) from the N-terminus of IgE-dependent histamine-releasing factor (HRF) and a target substance that is to be delivered into a cell. Also provided are nucleic acid molecules encoding the transmembrane complex, and methods of delivering the target substance into a cell interior by contacting the transmembrane complex with a cell. Also provided are transfection kits containing the PTD and the target substance.

Claims

exact text as granted — not AI-modified
1 . A method for delivering a target substance into a cell, comprising administering a transmembrane complex to a subject, wherein the complex comprises:
 a) a protein transduction domain (PTD) peptide that consists of the sequence of amino acids set forth in any of SEQ ID NOS: 39, 41, 43, 45, 26 and 27; and   b) a target substance that is linked to the PTD peptide, wherein:   the target substance is heterologous to the PTD peptide; and   the PTD peptide is linked to the target substance for delivery of the target substance into the interior of a cell, whereby the target substance is delivered into the cell.   
     
     
         2 . The method of  claim 1 , wherein the target substance is selected from among a nucleic acid, a drug, a chemical compound, a carbohydrate, a lipid, a glycolipid, an enzyme, a regulating factor, a growth factor and an antibody. 
     
     
         3 . The method of  claim 1 , wherein the PTD peptide is linked to the target substance via a linker.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.